Home
>
National Drug Code (NDC)
>
Releev Cold Sore Treatment
Releev Cold Sore Treatment - 63287-419-01 - (Benzalkonium Chloride)
Drug Information of Releev Cold Sore Treatment
| Product NDC: | 63287-419 |
| Proprietary Name: | Releev Cold Sore Treatment |
| Non Proprietary Name: | Benzalkonium Chloride |
| Active Ingredient(s): | 1.3 mg/mL & nbsp; Benzalkonium Chloride |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | LIQUID |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Releev Cold Sore Treatment
| Product NDC: | 63287-419 |
| Labeler Name: | Merix Pharmaceutical Corp. |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part333A |
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Start Marketing Date: | 20060601 |
Package Information of Releev Cold Sore Treatment
| Package NDC: | 63287-419-01 |
| Package Description: | 1 POUCH in 1 BLISTER PACK (63287-419-01) > 1 BOTTLE, DROPPER in 1 POUCH > 1 mL in 1 BOTTLE, DROPPER |
NDC Information of Releev Cold Sore Treatment
| NDC Code | 63287-419-01 |
| Proprietary Name | Releev Cold Sore Treatment |
| Package Description | 1 POUCH in 1 BLISTER PACK (63287-419-01) > 1 BOTTLE, DROPPER in 1 POUCH > 1 mL in 1 BOTTLE, DROPPER |
| Product NDC | 63287-419 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Benzalkonium Chloride |
| Dosage Form Name | LIQUID |
| Route Name | TOPICAL |
| Start Marketing Date | 20060601 |
| Marketing Category Name | OTC MONOGRAPH NOT FINAL |
| Labeler Name | Merix Pharmaceutical Corp. |
| Substance Name | BENZALKONIUM CHLORIDE |
| Strength Number | 1.3 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes |
